A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum

被引:122
作者
Herrera, Blanca [1 ]
Inman, Gareth J. [1 ]
机构
[1] Beatson Inst Canc Res, Growth Factor Signalling Lab, Glasgow G61 1BD, Lanark, Scotland
关键词
PROSTATE-CANCER; SIGNALING PATHWAYS; TGF-BETA; DIFFERENTIATION; CELLS; EXPRESSION; PROMOTER; METASTASES; INHIBITOR; DISEASE;
D O I
10.1186/1471-2121-10-20
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Bone morphogenetic proteins (BMPs) are pleiotropic members of the TGF-beta superfamily which regulate many biological processes during development and adult tissue homeostasis and are implicated in the pathogenesis of a number of human diseases. Their involvement in both normal and aberrant physiology creates a need for rapid, sensitive and methodologically simple assays to evaluate their activity from a variety of biological samples. Previously alkaline phosphatase based assays, ELISA and luciferase based bioassays have been developed to evaluate either individual or total BMP activity. In this paper, we describe a highly sensitive, rapid and specific cell based assay for the simultaneous quantification of total and isoform specific BMP activity from biological samples. Results: A C2C12 cell line stably transfected with a reporter plasmid consisting of the BMP response element (BRE) from the Id1 promoter fused to a luciferase reporter gene was generated. Exposure of this cell line to human recombinant BMP2, BMP4, BMP6, BMP7, BMP9 and BMP10 induced the expression of luciferase which was quantified using a luminometer. This assay was specific for BMP activity as the other TGF-beta superfamily members TGF-beta 1, Nodal and Mullerian Inhibiting Substance (MIS) did not induce the reporter. Pretreatment of samples with isoform specific BMP blocking antibodies coupled with isoform specific titration analysis allowed the simultaneous identification and quantification of BMP4, BMP6 and BMP9 in serum samples. Conclusion: The assay is rapid (<48 hours) and can be used to simultaneously measure isoform specific and total BMP activity in complex solutions.
引用
收藏
页数:11
相关论文
共 36 条
[1]   Genetics and mediators in pulmonary arterial hypertension [J].
Austin, Eric D. ;
Loyd, James E. .
CLINICS IN CHEST MEDICINE, 2007, 28 (01) :43-+
[2]   Bone morphogenetic protein 7 in the development and treatment of bone Metastases from breast cancer [J].
Buijs, Jeroen T. ;
Henriquez, Nico V. ;
Van Overveld, Petra G. M. ;
Van der Horst, Geertje ;
Que, Ivo ;
Schwaninger, Ruth ;
Rentsch, Cyrill ;
Ten Dijke, Peter ;
Cleton-Jansen, Anne-Marie ;
Driouch, Keltourna ;
Lidereau, Rosette ;
Bachelier, Richard ;
Vukicevic, Slobodan ;
Clezardin, Philippe ;
Papapoulos, Socrates E. ;
Cecchini, Marco G. ;
Loewik, Clemens W. G. M. ;
Van der Pluijm, Gabri .
CANCER RESEARCH, 2007, 67 (18) :8742-8751
[3]   BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo [J].
Buijs, Jeroen T. ;
Rentsch, Cyrill A. ;
van der Horst, Geertje ;
van Civerveld, Petra G. M. ;
Wetterwald, Antoinette ;
Schwaninger, Ruth ;
Henriquez, Niek V. ;
ten Dijke, Peter ;
Borovecki, Fran ;
Markwalder, Regula ;
Thalmann, George N. ;
Papapoulos, Socrates E. ;
Pelger, Rob C. M. ;
Vukicevic, Slobodan ;
Cecchini, Marco G. ;
Lowik, Clemens W. G. M. ;
van der Pluijm, Gabri .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (03) :1047-1057
[4]   Bone morphogenetic proteins [J].
Chen, D ;
Zhao, M ;
Mundy, GR .
GROWTH FACTORS, 2004, 22 (04) :233-241
[5]   Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate [J].
Chubinskaya, Susan ;
Frank, Benjamin S. ;
Michalska, Margaret ;
Kumar, Bhavna ;
Merrihew, Charis A. ;
Thonar, Eugene J-Ma ;
Lenz, Mary Ellen ;
Otten, Lori ;
Rueger, David C. ;
Block, Joel A. .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (03)
[6]   ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry [J].
Cruzalegui, FH ;
Cano, E ;
Treisman, R .
ONCOGENE, 1999, 18 (56) :7948-7957
[7]   Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism [J].
Dai, JL ;
Keller, J ;
Zhang, J ;
Lu, Y ;
Yao, Z ;
Keller, ET .
CANCER RESEARCH, 2005, 65 (18) :8274-8285
[8]   Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma [J].
Daibata, Masanori ;
Nemoto, Yuiko ;
Bandobashi, Kentaro ;
Kotani, Norihiro ;
Kuroda, Masayuki ;
Tsuchiya, Matsumi ;
Okuda, Heiwa ;
Takukawa, Tetsuya ;
Imai, Shosuke ;
Shuin, Taro ;
Taguchi, Hirokuni .
CLINICAL CANCER RESEARCH, 2007, 13 (12) :3528-3535
[9]   BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype [J].
Darby, S. ;
Cross, S. S. ;
Brown, N. J. ;
Hamdy, F. C. ;
Robson, C. N. .
JOURNAL OF PATHOLOGY, 2008, 214 (03) :394-404
[10]   Cerebrospinal fluid contains biologically active bone morphogenetic protein-7 [J].
Dattatreyamurty, B ;
Roux, E ;
Horbinski, C ;
Kaplan, PL ;
Robak, LA ;
Beck, HN ;
Lein, P ;
Higgins, D ;
Chandrasekaran, V .
EXPERIMENTAL NEUROLOGY, 2001, 172 (02) :273-281